ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1715

Predictors of Gastrointestinal and Renal Involvement in Adult IgA Vasculitis

Alojzija Hocevar1, Ziga Rotar 2 and Matija Tomšič 3, 1Department of Rheumatology, University Medical Center Ljubljana, Slovenia, LJUBLJANA, Slovenia, 2UMC LJUBLJANA, DPT. OF RHEUMATOLOGY, LJUBLJANA, Slovenia, 3Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, LJUBLJANA, Slovenia

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Henoch-Schönlein purpura, PREDICTOR, renal disease and gastrointestinal complications

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Behçet’s Disease & Other Vasculitides

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: IgA vasculitis (IgAV) is a common vasculitis of adult population, yet the disease in adults is still poorly defined. The aim of our study was to determine the predictors of gastrointestinal (GI) or renal involvement in adult IgAV

Methods: Medical records of histologically proven adult IgAV cases diagnosed between January 2013 and April 2019 at our secondary/tertiary rheumatology center were analyzed. The impact of 7 variables (age, gender, smoking, history of preceding infection, use of new medication prior IgAV, the extent of skin purpura (generalized above the waist vs. localized), and the presence of elevated serum immunoglobulin A (IgA) level) on the development of GI and renal involvement was evaluated using logistic regression models.

Results: During the 76-month observation period we identified 203 new adult IgAV cases (58.1% males, median (interquartile range) age 64 (47-76) years, 91 (44.8%) ever smokers). GI tract and renal involvement developed in 55 (27.1%) and 78 (38.4%) cases, respectively. Clinical characteristics of IgAV patients are presented in Table 1. In a multivariate logistic regression model generalized purpura increased (OR 5.45 (95%CI 2.56 – 11.59), p< 0.001) and elevated serum IgA level decreased (OR 0.45 (95%CI 0.21 – 0.95), p=0.037) GI tract involvement. Current smoking (OR 3.04 (1.34-6.89), p=0.008), generalized purpura (OR 1.97 (95%CI 1.06-3.65), p=0.032), elevated serum IgA (OR 1.96 (95%CI 1.02-3.74), p=0.041), and marginally also age (OR 1.02 (95%CI 1.01-1.04), p=0.012,) were associated with an increased risk of renal involvement in our cohort. Gender and potential triggers of IgAV (i.e. prior infections, and the use of new medication) did not significantly influence the clinical presentation of adult IgAV.

Conclusion: Generalized purpura predicted both renal and GI involvement in adult IgAV, active smoking renal involvement, while the serum IgA level had a divergent effect on renal and GI involvement.

Table 1. Clinical characteristics of IgAV cases


Disclosure: A. Hocevar, None; Z. Rotar, AbbVie, 9, Amgen, 5, 8, Eli-Lilly, 9, MSD, 5, Novartis, 9, Pfizer, 9, Sanofi, 5; M. Tomšič, None.

To cite this abstract in AMA style:

Hocevar A, Rotar Z, Tomšič M. Predictors of Gastrointestinal and Renal Involvement in Adult IgA Vasculitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/predictors-of-gastrointestinal-and-renal-involvement-in-adult-iga-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-gastrointestinal-and-renal-involvement-in-adult-iga-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology